Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gerard

Showing results (301-310 of 307) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 307 results.
Genome Medicine|July 3, 2026
Human cancer genomes harbor the mutational signature of tobacco-specific nitrosamines NNN and NNKMichael Korenjak, Nuri Alpay Temiz, Stéphane Keita, et al.
Journal of Medicinal Chemistry|March 23, 2012
(1aR,5aR)1a,3,5,5a-Tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic acid (MK-1903): a potent GPR109a agonist that lowers free fatty acids in humansP Douglas Boatman, Brett Lauring, Thomas O Schrader, et al.
Science Translational Medicine|August 24, 2012
Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppressionBrett Lauring, Andrew K P Taggart, James R Tata, et al.
Science (New York, N.Y.)|June 9, 2021
Senolytics reduce coronavirus-related mortality in old miceChristina D Camell, Matthew J Yousefzadeh, Yi Zhu, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2016
Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA SynthetaseAndrés Palencia, Xianfeng Li, Wei Bu, et al.
Cell Chemical Biology|September 19, 2017
Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell MitochondriaZhijun Guo, Irina F Sevrioukova, Ilia G Denisov, et al.
Cell Chemical Biology|October 21, 2017
Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell MitochondriaZhijun Guo, Irina F Sevrioukova, Ilia G Denisov, et al.
Pageof 31

Showing results (301-310 of 307) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 307 results.
Genome Medicine|July 3, 2026
Human cancer genomes harbor the mutational signature of tobacco-specific nitrosamines NNN and NNKMichael Korenjak, Nuri Alpay Temiz, Stéphane Keita, et al.
Journal of Medicinal Chemistry|March 23, 2012
(1aR,5aR)1a,3,5,5a-Tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic acid (MK-1903): a potent GPR109a agonist that lowers free fatty acids in humansP Douglas Boatman, Brett Lauring, Thomas O Schrader, et al.
Science Translational Medicine|August 24, 2012
Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppressionBrett Lauring, Andrew K P Taggart, James R Tata, et al.
Science (New York, N.Y.)|June 9, 2021
Senolytics reduce coronavirus-related mortality in old miceChristina D Camell, Matthew J Yousefzadeh, Yi Zhu, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2016
Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA SynthetaseAndrés Palencia, Xianfeng Li, Wei Bu, et al.
Cell Chemical Biology|September 19, 2017
Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell MitochondriaZhijun Guo, Irina F Sevrioukova, Ilia G Denisov, et al.
Cell Chemical Biology|October 21, 2017
Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell MitochondriaZhijun Guo, Irina F Sevrioukova, Ilia G Denisov, et al.
Pageof 31